Literature DB >> 2543221

Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent.

J Levine1, D B Bernard, B A Idelson, H Farnham, C Saunders, A M Sugar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2543221     DOI： 10.1016/0002-9343(89)90481-6

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  13 in total

1.  Candida peritonitis: successful treatment with CAPD in two patients.

Authors:  M Méhes; L Mohai; G Szöllösy
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

2.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

3.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 4.  Fungal peritonitis in children on peritoneal dialysis.

Authors:  Renske Raaijmakers; Cornelis Schröder; Leo Monnens; Elisabeth Cornelissen; Adilla Warris
Journal:  Pediatr Nephrol       Date:  2006-11-17       Impact factor: 3.714

Review 5.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

Review 6.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

7.  Fluconazole treatment of candidal infections caused by non-albicans Candida species.

Authors:  J W van 't Wout
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

Review 8.  Clinical pharmacokinetics of fluconazole.

Authors:  D Debruyne; J P Ryckelynck
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

9.  The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.

Authors:  Satoshi Sobue; Keith Tan; Gary Layton; Violette Leclerc; Angelika Weil
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

10.  Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading.

Authors:  E Anaissie; V Paetznick; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.